From the onset of the novel coronavirus outbreak, QIAGEN’s dedicated global teams have been working around the clock to ensure the availability of existing testing solutions and to develop new SARS-CoV-2 tests to address international testing needs.
Today, we offer a comprehensive portfolio of SARS-CoV-2 testing solutions on the market, covering the needs of clinical and research customers, from manual to automated sample processing, low to high throughput, single-plex to multi-plex, and from active infection testing to the detection of previous viral exposure.
Stay up to date with the latest news, product developments and stories covering our global efforts in the fight against COVID-19.
QIAGEN COVID-19 solutions
Learn more about our comprehensive diagnostic and research portfolio
In the media